Inhibikase Therapeutics Inc
(NAS:IKT)
$
2.47
+0.060 (+2.49%)
Market Cap: 387.87 Mil
Enterprise Value: 300.24 Mil
PE Ratio: 0
PB Ratio: 1.94
GF Score: 36/100 Inhibikase Therapeutics Inc (IKT) Transcripts
- 1